Brookline Capital raises Kymera stock price target on lupus drug data
Brookline Capital raises Kymera stock price target on lupus drug data
Brookline Capital raises Kymera stock price target on lupus drug data
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.